Preparation of 1-(4-methoxyphenyl)-1H-pyrazolo[4,3-d]pyrimidin-7(6H)-ones as potent, selective and bioavailable inhibitors of coagulation factor Xa
- 15 July 2006
- journal article
- research article
- Published by Elsevier BV in Bioorganic & Medicinal Chemistry Letters
- Vol. 16 (14), 3755-3760
- https://doi.org/10.1016/j.bmcl.2006.04.044
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Aminobenzisoxazoles with biaryl P4 moieties as potent, selective, and orally bioavailable factor Xa inhibitorsBioorganic & Medicinal Chemistry Letters, 2006
- Factor Xa inhibitors in acute coronary syndromes: moving from mythology to realityJournal of Thrombosis and Haemostasis, 2005
- Rationale for the use of antifactor Xa in the treatment and prevention of venous and arterial thromboembolic eventsEuropean Journal of Clinical Investigation, 2005
- New anticoagulantsBlood, 2005
- Discovery of 1-(3‘-Aminobenzisoxazol-5‘-yl)-3-trifluoromethyl-N-[2-fluoro-4- [(2‘-dimethylaminomethyl)imidazol-1-yl]phenyl]-1H-pyrazole-5-carboxyamide Hydrochloride (Razaxaban), a Highly Potent, Selective, and Orally Bioavailable Factor Xa InhibitorJournal of Medicinal Chemistry, 2004
- Clinical and Experimental Experience with Factor Xa InhibitorsAmerican Journal of Cardiovascular Drugs, 2004
- Discovery of 1-(2-Aminomethylphenyl)-3-trifluoromethyl-N- [3-fluoro-2‘-(aminosulfonyl)[1,1‘-biphenyl)]-4-yl]-1H-pyrazole-5-carboxyamide (DPC602), a Potent, Selective, and Orally Bioavailable Factor Xa InhibitorJournal of Medicinal Chemistry, 2003
- Nonpeptide Factor Xa Inhibitors III: Effects of DPC423, an Orally-Active Pyrazole Antithrombotic Agent, on Arterial Thrombosis in RabbitsThe Journal of pharmacology and experimental therapeutics, 2002
- Methods of Determining Plasma and Tissue Binding of DrugsClinical Pharmacokinetics, 1992
- PREPARATION OF TRIFLUOROACETONITRILE PHENYLIMINE AND ITS REACTIONS WITH SOME DIPOLAROPHILESChemistry Letters, 1982